Literature DB >> 24142298

Flavones derived from nature attenuate the immediate and late-phase asthmatic responses to aerosolized-ovalbumin exposure in conscious guinea pigs.

Ji-Yun Lee1, Jung Min Kim, Chang Jong Kim.   

Abstract

OBJECTIVE: Asthma is an inflammatory disease of the lung that is characterized by airway hyperresponsiveness and the increase of inflammatory cell infiltration into the airways. Naturally occurring flavones have potent anti-inflammatory effects, but their effects on asthmatic responses are still relatively unknown.
METHODS: We evaluated the inhibitory effects of flavone derivatives having the chromone moiety on the immediate-phase asthmatic response (IAR) and the late-phase asthmatic response (LAR) to aerosolized-ovalbumin (OA) exposure in conscious OA-sensitized guinea pigs.
RESULTS: Luteolin and apigenin (30 mg/kg, p.o.) significantly (P < 0.05) decreased not only the specific airway resistance (sRaw) in IAR and LAR, but also the recruitment of leukocytes and the release of histamine and activities of phospholipase A2 (PLA2) and eosinophil peroxide (EPO) in bronchoalveolar lavage fluid (BALF), compared to control. However, their anti-asthmatic activities were less than those of cromolyn sodium and dexamethasone.
CONCLUSIONS: These results indicate that flavones containing more hydroxyl radicals have a greater anti-asthmatic effect. The potencies of flavone anti-asthmatic activities are, in order: luteolin ≥ apigenin > baicalein > chrysin > flavone.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24142298     DOI: 10.1007/s00011-013-0670-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  30 in total

1.  Anti-inflammatory effects of ivermectin in mouse model of allergic asthma.

Authors:  Shuhan Yan; Xinxin Ci; Na Chen; Chi Chen; Xiangchao Li; Xiao Chu; Jianhua Li; Xuming Deng
Journal:  Inflamm Res       Date:  2011-01-29       Impact factor: 4.575

2.  Comparison between bronchial and alveolar samples of bronchoalveolar lavage fluid in asthma.

Authors:  T Van Vyve; P Chanez; J Y Lacoste; J Bousquet; F B Michel; P Godard
Journal:  Chest       Date:  1992-08       Impact factor: 9.410

3.  A noninvasive technique for measurement of changes in specific airway resistance.

Authors:  B E Pennock; C P Cox; R M Rogers; W A Cain; J H Wells
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-02

4.  Flavonols attenuate the immediate and late-phase asthmatic responses to aerosolized-ovalbumin exposure in the conscious guinea pig.

Authors:  Chan Hun Jung; Ji Yun Lee; Jin Hyung Park; Bong Jae Cho; Sang Soo Sim; Chang Jong Kim
Journal:  Fitoterapia       Date:  2010-05-10       Impact factor: 2.882

5.  Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine.

Authors:  D W Cockcroft; K Y Murdock
Journal:  J Allergy Clin Immunol       Date:  1987-05       Impact factor: 10.793

6.  Quercetin inhalation inhibits the asthmatic responses by exposure to aerosolized-ovalbumin in conscious guinea-pigs.

Authors:  Hee Moon; Hyun Ho Choi; Ji Yun Lee; Hyo Jin Moon; Sang Soo Sim; Chang Jong Kim
Journal:  Arch Pharm Res       Date:  2008-06-19       Impact factor: 4.946

7.  Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs.

Authors:  S Sanjar; S Aoki; A Kristersson; D Smith; J Morley
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

Review 8.  Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties.

Authors:  Giuseppe Galati; Peter J O'Brien
Journal:  Free Radic Biol Med       Date:  2004-08-01       Impact factor: 7.376

Review 9.  Flavonoids, a class of natural products of high pharmacological potency.

Authors:  B Havsteen
Journal:  Biochem Pharmacol       Date:  1983-04-01       Impact factor: 5.858

10.  Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line.

Authors:  Y-D Min; C-H Choi; H Bark; H-Y Son; H-H Park; S Lee; J-W Park; E-K Park; H-I Shin; S-H Kim
Journal:  Inflamm Res       Date:  2007-05       Impact factor: 4.575

View more
  6 in total

1.  The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.

Authors:  Zuyi Weng; Arti B Patel; Smaro Panagiotidou; Theoharis C Theoharides
Journal:  J Allergy Clin Immunol       Date:  2014-12-10       Impact factor: 10.793

Review 2.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

3.  Mechanism of Action of Yin Nourishing and Heat Clearing Prescription in Treating Cough Variant Asthma Based on Network Pharmacology and Molecular Docking Verification.

Authors:  Yin Zhang; Yixin Cui; Qi Chen; Fagen Li; Shaodan Li
Journal:  Comput Math Methods Med       Date:  2022-07-12       Impact factor: 2.809

4.  Adjustment of sensitisation and challenge protocols restores functional and inflammatory responses to ovalbumin in guinea-pigs.

Authors:  Alexander P P Lowe; Kenneth J Broadley; Anthony T Nials; William R Ford; Emma J Kidd
Journal:  J Pharmacol Toxicol Methods       Date:  2014-10-30       Impact factor: 1.950

5.  Inhibitory effects of 2,6-di-tert-butyl-4-hydroxymethylphenol on asthmatic responses to ovalbumin challenge in conscious guinea pigs.

Authors:  Seul-Yong Jeong; Ji-Yun Lee
Journal:  Korean J Physiol Pharmacol       Date:  2017-12-22       Impact factor: 2.016

6.  Baicalein induces CD4(+)Foxp3(+) T cells and enhances intestinal barrier function in a mouse model of food allergy.

Authors:  Min-Jung Bae; Hee Soon Shin; Hye-Jeong See; Sun Young Jung; Da-Ae Kwon; Dong-Hwa Shon
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.